Natural Biocon (India) Ltd
NSE: BSE: 543207
₹4.20
(-5.83%)
Tue, 03 Mar 2026, 00:17 pm
Market Cap108.29M
PE Ratio0
Dividend0
Process Industries
Chemicals: Specialty
24.5KNatural Biocon (India) Analysis
dividend
- Unable to evaluate Natural Biocon (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Natural Biocon (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Natural Biocon (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Natural Biocon (India) has been profitable on average in the past, therefore cash runway is not a concern.
- Natural Biocon (India) has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 1.6x debt.
- Natural Biocon (India)'s cash and other short term assets cover its long term commitments.
- Natural Biocon (India)'s level of debt (6.5%) compared to net worth is satisfactory (less than 40%).
- Operating cash flow is negative therefore debt is not well covered.
- High level of physical assets or inventory.
management
- The average tenure for the Natural Biocon (India) board of directors is less than 3 years, this suggests a new board.
misc
- Natural Biocon (India) is not covered by any analysts.
- Natural Biocon (India)'s last earnings update was 238 days ago.
past
- Unable to compare Natural Biocon (India)'s 1-year earnings growth to the 5-year average as it is not currently profitable.
- Natural Biocon (India) does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Natural Biocon (India) has efficiently used its assets last year compared to the IN Market industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Natural Biocon (India) improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Natural Biocon (India) has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Natural Biocon (India)'s 1-year growth to the IN Market industry average as it is not currently profitable.
value
- Natural Biocon (India) is overvalued based on assets compared to the IN Market industry average.
- Natural Biocon (India) is overvalued based on earnings compared to the IN Market industry average.
- Natural Biocon (India) is overvalued based on earnings compared to the India market.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800